New classes of optogenetic and chemogenetic tools with a feedback control
Project Number1DP2MH132939-01
Former Number1DP2OD032648-01
Contact PI/Project LeaderWANG, WENJING
Awardee OrganizationUNIVERSITY OF MICHIGAN AT ANN ARBOR
Description
Abstract Text
New classes of optogenetic and chemogenetic tools with a feedback control
Project Summary
Optogenetic and chemogenetic tools have revolutionized neuroscience research. They also hold great
promise for gene therapy of neurological disorders, such as epilepsy, schizophrenia and anxiety disorders.
For example, among the ~ 65 million people worldwide affected by epilepsy, 30% of them are resistant to
current medicine but could significantly benefit from new therapies that can quickly and effectively suppress
the irregular neuronal activities during seizures. However, we currently lack tools for prolonged neuronal
silencing with fast response to precisely modulate the irregular neuronal activities in neurological disorders
for both neuroscience research and therapeutic development. The state-of-the-art optogenetic tools for
neuromodulation provide fast temporal control via light, but they are limited by light-induced tissue heating in
long-lasting neuronal silencing experiments. Existing chemogenetic tools are effective for long-term neuronal
silencing, however, they are limited by their slow on/off rate due to drug administration. There is a need of
new tools that will enable prolonged neuronal silencing in quick response to the irregular neuronal activities
in neurological disorders. Our long-term goal is to engineer modular biological designs for controlling the
activities of specific neuronal pathways with tunable temporal control and minimal invasiveness for
neuroscience research and potential therapeutics. In this application, we propose to design the first closed-
loop chemogenetic tool with a feedback control to suppress the irregularly-high neuronal activities, and a
highly-light-sensitive optogenetic tool to achieve long-lasting silencing of neuronal activities. These new tools
based on membrane-tethered temporally-gated peptide agonists for G-protein-coupled receptors are highly
innovative and modular, and will open up a new frontier in designing neuromodulation tools for manipulating
neuronal pathways. They will also advance the basic research on neuronal circuitry and facilitate the
development of potential therapeutics for manipulating neuronal pathways in patients with neurological
disorders.
Public Health Relevance Statement
New classes of optogenetic and chemogenetic tools with a feedback control
Project Narrative
Neurological disorders, such as epilepsy and schizophrenia, are very debilitating by showing
unpredicted episodes of irregular neuronal activities. We propose to develop new optogenetic tools with
tunable temporal control and new chemogenetic tools with a feedback control to precisely silence the
irregular neuronal activities in neurological disorders. These new tools will significantly facilitate
neuroscience studies to advance our understanding of the disease mechanism and provide potential
therapeutic treatment.
No Sub Projects information available for 1DP2MH132939-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1DP2MH132939-01
Patents
No Patents information available for 1DP2MH132939-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1DP2MH132939-01
Clinical Studies
No Clinical Studies information available for 1DP2MH132939-01
News and More
Related News Releases
No news release information available for 1DP2MH132939-01
History
No Historical information available for 1DP2MH132939-01
Similar Projects
No Similar Projects information available for 1DP2MH132939-01